Results 21 to 30 of about 40,451 (242)

Assessment of risk factors for congenital heart disease through prenatal fetal echocardiography and the correlation with postnatal diagnoses

open access: yesTrends in Pediatrics, 2023
Background: Congenital Heart Disease (CHD) constitutes a significant cause of morbidity and mortality in newborns. Identifying CHD prenatally and understanding associated risk factors can aid in early diagnosis, intervention, and postnatal management ...
Kaan Yıldız   +10 more
doaj   +1 more source

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production [PDF]

open access: yes, 2018
The ErbB2 blocker trastuzumab improves survival in oncologic patients, but can cause cardiotoxicity. The late Na+ current inhibitor ranolazine has been shown to counter experimental HF, including doxorubicin cardiotoxicity (a condition characterized by ...
Carlo G. Tocchetti   +16 more
core   +3 more sources

A journey from adult to fetal echocardiography

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2018
As a cardiologist in a group practice or hospital settings, many a times you are requested to comment on fetal Echocardiography performed by radiologist or fetal medicine specialist.
U P Singh, Hargunbir Singh, Ladbans Kaur
doaj   +1 more source

4D Fetal Echocardiography [PDF]

open access: yes, 2012
Congenital heart defects (CHD) are the most frequent malformation in the human fetus and are the leading cause of mortality due to malformations in the first year of life. Despite its clinical importance screening performed by ultrasonographic examination during the second trimester of pregnancy has shown disappointingly low detection rates mainly due ...
RIZZO, GIUSEPPE, ARDUINI, DOMENICO
openaire   +3 more sources

Myocardial Dysfunction in an Animal Model of Cancer Cachexia [PDF]

open access: yes, 2011
Aims Fatigue is a common occurrence in cancer patients regardless of tumor type or anti-tumor therapies and is an especially problematic symptom in persons with incurable tumor disease.
Crawford, Danielle   +7 more
core   +2 more sources

Myocardial Function Maturation in Very-Low-Birth-Weight Infants and Development of Bronchopulmonary Dysplasia [PDF]

open access: yes, 2019
Background: Myocardial function in very-low-birth-weight infants (VLBWIs) develops during early postnatal life, but different patterns of temporal evolution that might be related to the development of bronchopulmonary dysplasia (BPD) are not completely ...
Benavente Fernández, Isabel   +3 more
core   +2 more sources

Awareness of fetal echo in Indian scenario

open access: yesAnnals of Pediatric Cardiology, 2012
Background: Fetal echocardiography is a well established sensitive tool to diagnose congenital heart disease (CHD) in utero. One of the determinants of effective utilization of fetal echocardiography is its awareness in the general population.
Dhanya Warrier   +4 more
doaj   +1 more source

Acquired heart block: A possible complication of patent ductus arteriosus in a preterm infant [PDF]

open access: yes, 2008
A large patent ductus arteriosus (PDA) is a frequently encountered clinical problem in extremely low birth weight (ELBW) infants. It leads to an increased pulmonary blood flow and in a decreased or reversed diastolic flow in the systemic circulation ...
Andreas Holzinger   +14 more
core   +1 more source

Fetal heart quantification technique improves the prenatal prediction of coarctation of the aorta: A retrospective analysis

open access: yesBiomolecules & Biomedicine
Coarctation of the aorta (CoA) ranks among the most prevalent congenital heart defects and poses a life-threatening risk if left undiagnosed. Herein, we utilized fetal HQ technology to improve the prenatal prediction of CoA.
Xiaoxi Lu   +7 more
doaj   +1 more source

Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. [PDF]

open access: yes, 2015
BackgroundNoninvasive prenatal screening (NIPS) by next-generation sequencing of cell-free DNA (cfDNA) in maternal plasma is used to screen for common aneuploidies such as trisomy 21 in high risk pregnancies.
Chu, Tianjiao   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy